COMPOUNDS AND USES THEREOF IN MODULATING LEVELS OF VARIOUS AMYLOID BETA PEPTIDE ALLOFORMS
申请人:Wagner Steven L.
公开号:US20130165416A1
公开(公告)日:2013-06-27
The invention provides a novel compound having a structure corresponding to Formula (I):
(A)-(B)—(C)-(D) (I)
or a pharmaceutically acceptable salt or prodrug thereof and methods for using them.
Disclosed is a class of porcupine inhibitors, specifically a compound as represented by formula (I), and a pharmaceutically acceptable salt or an isomer thereof.
公开了一类豪猪抑制剂,特别是一种由公式(I)表示的化合物及其药学上可接受的盐或异构体。
[EN] COMPOUND AS PORCUPINE INHIBITOR AND USE THEREOF<br/>[FR] COMPOSÉ UTILISÉ EN TANT QU'INHIBITEUR DE PORC-ÉPIC ET SON UTILISATION<br/>[ZH] 作为porcupine抑制剂的化合物及其应用
申请人:MEDSHINE DISCOVERY INC
公开号:WO2021004467A1
公开(公告)日:2021-01-14
一类porcupine抑制剂,具体公开了式(I)所示化合物、其药学上可接受的盐或其异构体。
INSECTICIDAL COMPOUNDS BASED ON ARYLTHIOACETAMIDE DERIVATIVES
申请人:Syngenta Participations AG
公开号:EP2709983A1
公开(公告)日:2014-03-26
AZASPIRO DERIVATIVES AS TRPM8 ANTAGONISTS
申请人:RaQualia Pharma Inc.
公开号:US20170002016A1
公开(公告)日:2017-01-05
The present invention relates to azaspiro derivatives of the formula (I) or a pharmaceutically acceptable salt thereof or a prodrug thereof, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of various disorders which are mediated via the TRPM8 receptor.